VVP
ABBV icon

Venture Visionary Partners’s AbbVie ABBV Stock Holding History

Venture Visionary Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.7K Hold
100
– – ﹤0.01% 644
2025
Q4 		$22.8K Buy
+100
New +$22.8K ﹤0.01% 647

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Venture Visionary Partners's ABBV Position: Q1 2026 in Review

Venture Visionary Partners increased its AbbVie (ABBV) stake by 3.7% in Q1 2026, buying an estimated $273K and bringing the position to 34,685 shares worth $7.54M. The position accounts for 0.25% of the portfolio, ranked #106.

Venture Visionary Partners first reported a position in ABBV in Q4 2019 and has held it in 26 quarters since. The position peaked at $9.3M in Q1 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Venture Visionary Partners held 34,685 shares of AbbVie worth $7.54M as of Q1 2026.
  • Venture Visionary Partners bought 1,230 AbbVie shares in Q1 2026, an estimated $273K.
  • AbbVie made up 0.25% of Venture Visionary Partners's portfolio in Q1 2026, its #106 holding.
  • Venture Visionary Partners first reported a position in AbbVie in Q4 2019 and has held it in 26 quarters since.
  • Venture Visionary Partners's AbbVie position peaked at $9.3M in Q1 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Venture Visionary Partners's 13F filing for Q1 2026, filed 14 May 2026.